Enveric Biosciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+8.0% +$207K
$-2M
Free Cash Flow↑+8.0% +$207K
$-2M
Investing Cash Flow
—
Financing Cash Flow↑+478.0% +$2M
$3M
Capex
—
Acquisitions
—
Stock-Based Comp↓-49.4% -$183K
$187K
D&A↓-52.4% -$44K
$40K
SBC Allocated Expense↓-49.5% -$183K
$187K